Nanomedicine in diabetes management: where we are now and where next

References

• Morrow KJ, Bawa R, Wei C. Recent advances in basic and clinical nanomedicine. Med. Clin. North Am.91, 805–843 (2007).
   PubMed Web of Science ®Google Scholar
• Nanoscience and Nanotechnologies. Royal Society and Royal Academy of Engineering, London, UK 113 (2004).
   Google Scholar
• Pickup JC, Zhi ZL, Khan F, Saxl T, Birch DJ. Nanomedicine and its potential in diabetes research and practice. Diabetes Metab. Res. Rev.24, 604–610 (2008).
   Google Scholar
• Ariga K, Hill JP, Ji Q. Layer-by-layer assembly as a versatile bottom-up nanofabrication technique for exploratory research and realistic application. Phys. Chem. Chem. Phys.9, 2319–2340 (2007).
   PubMed Web of Science ®Google Scholar
• Trau D, Rennenberg R. Encapsulation of glucose oxidase microparticles within a nanoscale layer-by-layer film: immobilization and biosensor applications. Biosens. Bioelectron.18, 1491–1499 (2003).
   PubMed Web of Science ®Google Scholar
• Chinnayelka S, McShane MJ. Glucose sensors based on microcapsules containing an orange/red competitive binding resonance energy transfer assay. Diabetes Technol. Ther.8, 269–278 (2006).
   PubMed Web of Science ®Google Scholar
• McShane M, Ritter D. Microcapsules as optical biosensors. J. Mater. Chem. DOI: 10.1039/c0jm01251c (2010) (Epub ahead of print).
   Google Scholar
• Zhi ZL, Haynie DT. High-capacity functional protein encapsulation in nanoengineered polypeptide microcapsules. Chem. Commun. (Camb.)2, 147–149 (2006).
   PubMedGoogle Scholar
• Zhi Z-L, Haynie DT. Straightforward and effective protein encapsulation in polypeptide-based artificial cells. Artif. Cells Blood Substit. Immobil. Biotechnol.34, 189–203 (2006).
   PubMed Web of Science ®Google Scholar
• Saxl T, Khan F, Matthews DR et al. Fluorescence lifetime spectroscopy and imaging of nano-engineered glucose sensor microcapsules based on glucose/galactose-binding protein. Biosens. Bioelectron.24, 3229–3234 (2009).
   Google Scholar
• Beck J, Angus R, Madsen B et al. Islet encapsulation: strategies to enhance islet cell function. Tissue Eng.13, 589–599 (2007).
   PubMedGoogle Scholar
• Zhi Z-L, Liu B, Jones PM, Pickup JC. Polysacharide multilayer nanoencapsulation of insulin-producing β-cells grown as pseudoislets for potential cellular delivery of insulin. Biomacromolecules11, 610–616 (2010).
   Google Scholar
• Desai TA, West T, Cohen M, Boiarski T, Rampersaud A. Nanoporous microsystems for islet cell replacement. Adv. Drug Deliv. Rev.56, 1661–1673 (2004).
   PubMed Web of Science ®Google Scholar
• Khan F, Gnudi L, Pickup JC. Fluorescence-based sensing of glucose using engineered glucose/galactose-binding protein: a comparison of fluorescence resonance energy transfer and environmentally sensitive dye labelling strategies. Biochim. Biophys. Res. Comm.365, 102–106 (2008).
   Web of Science ®Google Scholar
• Khan F, Saxl TE, Pickup JC. Fluorescence intensity- and lifetime-based glucose sensing using an engineered high-Kd mutant of glucose/galactose-binding protein. Analyt. Biochem.399, 39–43 (2010).
   Web of Science ®Google Scholar
• Sona PS. Nanoparticulate drug delivery systems for the treatment of diabetes. Digest. J. Nanomater. Biostruct.5, 411–418 (2010).
   Web of Science ®Google Scholar
• Damgé C, Maincent P, Ubrich N. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J. Control. Release117, 163–170 (2007).
   PubMed Web of Science ®Google Scholar
• Lin Y-H, Mi F-L, Chen C-T et al. Preparation and characterization of nanoparticles shelled with chitosan for insulin delivery. Biomacromolecules8, 146–152 (2007).
   PubMed Web of Science ®Google Scholar
• Bhumkar DR, Joshi HM, Satry M, Pokharkar VB. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm. Res.24, 1415–1426 (2007).
   PubMed Web of Science ®Google Scholar
• Chalasani KB, Russell-Jones GJ, Yandrapu SK, Diwan PV, Jain SK. A novel vitamin B12-nanosphere conjugare carrier system for peroral delivery of insulin. J. Control. Release117, 421–429 (2007).
   PubMed Web of Science ®Google Scholar
• Tsai S, Shamelli A, Yamanouchi J et al. Reversal OD autoimmunity by boosting memory-like autoregulatory T cells. Immunity32, 568–580 (2010).
   PubMed Web of Science ®Google Scholar
• Barone PW, Parker RS, Strano MS. In vivo fluorescence detection of glucose using a single-walled carbon nanotube optical sensor: design, fluorphore properties, advantages, and disadvantages. Anal. Chem.77, 756–7562 (2005).
   Google Scholar
• Barone PW, Yoon H, Ortiz-Garcia R et al. Modulation of single-walled carbon nanotube photoluminescence by hydrogel swelling. ACS Nano12, 3869–3877 (2009).
   Google Scholar
• Michalet X, Pinaud FF, Bentolila LA et al. Quantum dots for live cells, in vivo imaging, and diagnostics. Science307, 538–544 (2005).
   PubMed Web of Science ®Google Scholar
• Tang B, Cao L, Xu K et al. A new biosensor for glucose with high sensitivity and selectivity in serum based on fluorescence resonance energy transfer (FRET) between CdTe quantum dots and Au nanoparticles. Chem. Eur. J.14, 3637–3644 (2008).
   PubMed Web of Science ®Google Scholar
• Denis MC, Mahmood U, Benoist C, Mathias D, Weissleder R. Imaging inflammation of the pancreatic islets in Type 1 diabetes. Proc. Natl Acad. Sci. USA101, 12634–12639 (2004).
   PubMed Web of Science ®Google Scholar
• Cavalcanti A, Shirinzadeh B, Kretly LC. Medical nanorobotics for diabetes control. Nanomedicine4, 127–138 (2008).
   PubMed Web of Science ®Google Scholar
• Napoli A, Boerakker MJ, Tirelli N et al. Glucose-oxidase based self-destructing polymeric vesicles. Langmuir20, 3487–3491 (2004).
   PubMed Web of Science ®Google Scholar